Rapid Syphilis Tests Show Economic, Clinical Benefits for High-Risk Populations
Monash University study finds different testing algorithms work best for pregnant women versus men who have sex with men.
Monash University study finds different testing algorithms work best for pregnant women versus men who have sex with men.
NOWDiagnostics has launched the First To Know Syphilis Test, an FDA-authorized over-the-counter syphilis test in the U.S.
WHO invited manufacturers of mpox IVDs to submit expressions of interest for Emergency Use Listing in response to rising cases in Africa.
A study by FAIR Health reveals a 4.8 percent increase in STD diagnoses among commercially insured patients from 2020 to 2023.
Read MoreResearchers developed a new lab test to detect intact HIV infections with African strains, crucial for advancing global HIV cure efforts.
Read MoreSyphilis cases are rising globally, yet many Americans remain unaware of its symptoms and treatment options.
Read MoreThere has been significant rise in sexually transmitted infections (STIs), underscoring the need for improved STI testing and diagnostics.
Read MoreSyphilis cases in Tennessee have surged among women, due to insufficient prenatal testing and treatment, compounded by a penicillin shortage.
Read MoreTestmate Health secured $6 million in seed funding to develop an OTC self-test for STIs, initially targeting chlamydia and gonorrhea.
Read MoreScout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Read MoreTo increase the amount of syphilis testing, labs need to remove moral judgement and acknowledge the STI as just another infection.
Read MoreTo stem the tide of the STI epidemic, health care must work together through education, prevention, screening, diagnosis, and treatment.
Read MoreThee American Medical Association launched a new toolkit to help increase screenings for HIV, STIs, viral hepatitis and latent tuberculosis.
Read MoreEmphasizing the healthcare disparities through increased testing for effective prevention of congenital syphilis needs addressing.
Read MoreNOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company’s First to Know at-home syphilis test.
Read MoreThe FDA is providing this information to educate health care providers and clinical laboratory staff and reduce the risk of false results.
Read MoreThe company began commercial shipments as part of the initial purchase order for 2.5 million tests, with further shipments scheduled.
Read MoreQuidelOrtho received 510(K) clearance from the FDA for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test
Read More